We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
-7.99%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.4B
AUM Growth
-$2.28B
Cap. Flow
-$623M
Cap. Flow %
-3.38%
Top 10 Hldgs %
32.43%
Holding
345
New
22
Increased
43
Reduced
37
Closed
30

Sector Composition

Rank Sector Weight
1 Healthcare 30.97%
2 Technology 17.59%
3 Financials 14.68%
4 Industrials 9.18%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCVI
126
DELISTED
Churchill Capital Corp VI
CCVI
$9.77M 0.05%
997,767
+215,000
+27% +$2.11M
SCRM
127
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$9.59M 0.05%
1,000,000
NUVB icon
128
Nuvation Bio
NUVB
$2.43B
$9.4M 0.05%
2,900,000
COGT icon
129
Cogent Biosciences
COGT
$6.37B
$9.02M 0.05%
1,000,000
+150,000
+18% +$1.02M
NETC
130
DELISTED
Nabors Energy Transition Corp.
NETC
$9M 0.05%
900,000
GETR
131
DELISTED
Getaround, Inc.
GETR
$8.64M 0.05%
882,647
RXRA
132
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
$8.37M 0.05%
854,961
GTPB
133
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$8.25M 0.04%
843,046
PSPC
134
DELISTED
Post Holdings Partnering Corporation
PSPC
$8.23M 0.04%
848,184
NTRA icon
135
Natera
NTRA
$47.9B
$8.17M 0.04%
230,552
-870,700
-79% -$32.2M
CPAR
136
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$8.14M 0.04%
835,638
JWSM
137
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$7.86M 0.04%
800,000
ARYD
138
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$7.86M 0.04%
800,000
LCA
139
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$7.85M 0.04%
802,028
LVRA
140
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$7.82M 0.04%
800,000
KCGI
141
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$7.67M 0.04%
775,200
MPRA
142
DELISTED
Mercato Partners Acquisition Corporation Class A Common Stock
MPRA
$7.47M 0.04%
750,000
SLAC
143
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$7.37M 0.04%
750,000
APGB
144
DELISTED
Apollo Strategic Growth Capital II
APGB
$7.37M 0.04%
750,000
MVLA
145
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$7.37M 0.04%
750,000
WPCB
146
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$7.35M 0.04%
750,000
RACB
147
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$7.35M 0.04%
750,000
PANA
148
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$7.33M 0.04%
750,000
ARYE
149
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$7.24M 0.04%
745,000
STRE
150
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
$6.85M 0.04%
700,000

Similar funds

Thomas Steyer's Q2 2022 Portfolio in Review

As of Q2 2022, Thomas Steyer held 345 positions worth $18.4B, down 11% from $20.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Thomas Steyer withdrew a net $623M in Q2 2022, closing 30 positions and reducing 37 holdings. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $411M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Twitter, Inc. worth $274M.

  • Thomas Steyer's largest Q2 2022 buy was Twitter, Inc.: 7,325,000 shares worth $274M.
  • Thomas Steyer added most to Clarivate in Q2 2022, an estimated $237M increase.
  • Thomas Steyer's biggest Q2 2022 reduction was AbbVie, cutting an estimated $97.7M.
  • Thomas Steyer fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $411M.
  • Thomas Steyer's ten largest holdings make up 32% of its $18.4B portfolio in Q2 2022.
  • Thomas Steyer opened 22 new positions and closed 30 in Q2 2022.
  • Thomas Steyer's portfolio value fell 11% quarter-over-quarter to $18.4B.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.